Stage III laryngeal cancer represents a critical point in the disease where treatment decisions significantly impact both survival and quality of life. At this stage, cancer has either spread within the larynx affecting vocal cord movement, or has reached a nearby lymph node, but has not yet traveled to distant parts of the body. Understanding treatment options, from established surgical approaches to innovative therapies being tested in clinical trials, empowers patients and families to make informed decisions during this challenging time.

Understanding Treatment Goals for Advanced Laryngeal Cancer

When laryngeal cancer reaches stage III, treatment aims to eliminate cancer cells, preserve as much throat function as possible, and prevent the disease from progressing further. At this stage, the cancer has grown significantly within the larynx (the voice box in your throat that contains the vocal cords) or has spread to one nearby lymph node (small bean-shaped structures that filter harmful substances and fight infection). The good news is that stage III laryngeal cancer has not yet spread to distant organs, which means aggressive treatment can still control or potentially cure the disease.^[1]

Treatment decisions depend heavily on where in the larynx the cancer started. The larynx has three main areas: the supraglottis (above the vocal cords), the glottis (where the vocal cords are located), and the subglottis (below the vocal cords). Stage III cancer can occur in any of these regions, and each location requires slightly different treatment considerations.^[3] Additionally, doctors consider whether the cancer has made one or both vocal cords unable to move, which significantly affects voice production and breathing.

The medical community has witnessed significant changes in how stage III laryngeal cancer is treated over recent decades. Traditional approaches focused primarily on removing the cancer through surgery, even if it meant removing the entire larynx. Today, there is greater emphasis on preserving the larynx and its functions whenever possible, while still achieving good cancer control. This shift reflects advances in radiation technology, chemotherapy drugs, and a better understanding of which patients benefit most from different treatment approaches.^[14]

Both standard treatments approved by medical societies and experimental therapies in clinical trials offer hope to patients diagnosed with stage III laryngeal cancer. Standard treatments have years of research backing their effectiveness and safety, while clinical trials explore promising new drugs and techniques that might improve outcomes even further. Your medical team will work with you to develop a personalized treatment plan that balances cancer control with maintaining your ability to speak, swallow, and breathe as normally as possible.

Standard Treatment Approaches for Stage III Laryngeal Cancer

Standard treatment for stage III laryngeal cancer typically involves one of two main approaches: surgery-based treatment or radiation therapy combined with chemotherapy. Both approaches aim to eliminate the cancer while preserving as much function as possible. The choice between these options depends on tumor location, vocal cord function, patient preferences, and overall health status.^[8]

Surgical Treatment Options

Surgery remains a primary treatment option for many patients with stage III laryngeal cancer. The goal is to remove all cancerous tissue along with a margin of healthy tissue around it. For some stage III cancers, surgeons can perform transoral surgery, which means operating through the mouth without making external incisions. This approach uses specialized instruments and sometimes lasers to remove tumors while preserving surrounding healthy tissue.^[18]

When transoral surgery is not feasible due to tumor size or location, surgeons may perform open surgery, which involves making an incision in the neck. One common procedure is laryngopharyngectomy, which removes part or all of the larynx, part of the pharynx (throat), and sometimes a portion of the esophagus. This surgery is often necessary when the cancer has made swallowing or breathing difficult. During the same operation, surgeons typically perform a neck dissection, removing lymph nodes in the neck that may contain cancer cells.^[19]

Surgery for stage III laryngeal cancer may require additional procedures to help with breathing and nutrition. A tracheostomy creates an opening in the windpipe to help you breathe, which may be temporary or permanent depending on the extent of surgery. A feeding tube, usually a gastrostomy placed directly into the stomach, ensures adequate nutrition during recovery when swallowing is difficult or impossible. These procedures are part of comprehensive care to maintain your health throughout treatment.^[19]

Reconstructive surgery often accompanies cancer removal surgery. Plastic surgeons work to restore the appearance and function of the neck and throat as much as possible. This might involve using tissue from other parts of your body to rebuild structures that were removed. The goal is not just removing cancer but also helping you maintain a good quality of life after treatment.

According to research analyzing treatment outcomes in large patient populations, surgery-based treatment for stage III laryngeal cancer has shown favorable survival outcomes. Studies using sophisticated statistical methods to compare different treatment approaches found that patients who underwent surgery had significantly better disease-specific survival compared to those who received chemoradiotherapy alone.^[9] However, the decision must consider individual circumstances, including overall health, tumor characteristics, and patient preferences.

Radiation Therapy Combined with Chemotherapy

Chemoradiation has become a cornerstone treatment for stage III laryngeal cancer, particularly for patients who wish to preserve their larynx. This approach delivers radiation therapy and chemotherapy during the same time period, allowing the two treatments to work together. The chemotherapy makes cancer cells more vulnerable to radiation damage, increasing the effectiveness of the radiation.^[19]

Radiation therapy uses high-energy beams to kill cancer cells. For stage III laryngeal cancer, radiation is typically directed at the primary tumor in the larynx and the lymph nodes on both sides of the neck, even if only one side shows cancer. This comprehensive approach helps prevent cancer from spreading to untreated lymph nodes. Modern radiation techniques like Intensity-Modulated Radiation Therapy (IMRT) allow doctors to shape the radiation beam precisely to the tumor, minimizing damage to surrounding healthy tissues like the salivary glands, thyroid, and swallowing muscles.^[19]

The chemotherapy drug most commonly used with radiation for stage III laryngeal cancer is cisplatin. This platinum-based drug interferes with cancer cell division and makes the cells more sensitive to radiation damage. Cisplatin is typically given through an intravenous infusion every few weeks during the radiation treatment course. Some treatment protocols also use fluorouracil (also called 5-fluorouracil or 5-FU), another chemotherapy drug that disrupts cancer cell growth.^[19]

Chemoradiation treatment usually continues for several weeks. Patients receive radiation therapy five days per week, with chemotherapy administered on specific days according to the treatment protocol. The entire course typically lasts six to seven weeks. During this time, patients are monitored closely for side effects and effectiveness of treatment.

Radiation Therapy After Surgery

Many patients with stage III laryngeal cancer receive radiation therapy after surgery, a treatment approach called adjuvant radiation. This additional treatment targets any microscopic cancer cells that might remain after surgery, reducing the risk of cancer returning. If certain high-risk features are found during surgery—such as cancer cells at the edges of removed tissue or extensive lymph node involvement—doctors may recommend adding chemotherapy to the post-surgical radiation.^[19]

Side Effects of Standard Treatment

Both surgery and chemoradiation cause side effects that can significantly impact daily life. Understanding these effects helps patients prepare and manage them effectively. Surgical side effects depend on the extent of surgery but may include changes in voice quality or complete voice loss if the larynx is removed, difficulty swallowing, changes in neck appearance, and the need for a permanent breathing tube. Pain, fatigue, and risk of infection are common immediate post-surgical concerns.^[15]

Radiation therapy side effects typically worsen as treatment progresses and may include severe mouth and throat soreness, difficulty swallowing, dry mouth from damage to salivary glands, changes in taste, skin redness and irritation in the treatment area, fatigue, and hoarseness. These effects usually peak near the end of treatment and gradually improve over weeks to months afterward, though some like dry mouth may persist long-term.^[14]

Chemotherapy adds its own side effects to the treatment burden. Cisplatin commonly causes nausea and vomiting (which can be controlled with anti-nausea medications), hearing changes or ringing in the ears, kidney problems requiring careful fluid management, numbness or tingling in hands and feet, and increased susceptibility to infections due to low blood counts. Regular blood tests monitor for these effects during treatment.^[19]

Speech and swallowing therapy plays a crucial role in managing side effects and maintaining function during and after treatment. Speech and language therapists work with patients before treatment begins, continue support throughout therapy, and provide rehabilitation afterward. They teach exercises to maintain swallowing function, suggest dietary modifications to ensure adequate nutrition, and help patients adapt to voice changes. This support is essential for preserving quality of life.^[18]

Promising Treatments in Clinical Trials

Clinical trials offer patients access to cutting-edge treatments that may improve outcomes beyond what standard treatments provide. These studies carefully test new drugs, treatment combinations, and approaches before they become widely available. Participating in a clinical trial means contributing to medical knowledge while potentially benefiting from innovative therapies.

Immunotherapy in Clinical Development

One of the most exciting developments in laryngeal cancer treatment involves immunotherapy, which harnesses the body’s immune system to fight cancer. Unlike chemotherapy that directly kills cancer cells, immunotherapy helps immune cells recognize and attack cancer that would otherwise hide from immune detection. For stage III laryngeal cancer classified as locally advanced, researchers are studying immunotherapy drugs called checkpoint inhibitors.^[19]

Pembrolizumab (brand name Keytruda) represents a promising immunotherapy approach currently being tested for locally advanced laryngeal and related cancers. This drug works by blocking a protein called PD-1 on immune cells, essentially releasing the brakes that cancer uses to hide from the immune system. In clinical trials, pembrolizumab may be given before surgery to shrink tumors, making them easier to remove completely. After surgery, it is combined with radiation therapy (with or without cisplatin chemotherapy), and then continued by itself after radiation finishes.^[19]

This sequenced approach—using immunotherapy at multiple treatment stages—aims to attack cancer from different angles. Pre-surgical immunotherapy can stimulate an immune response against the tumor. Combining it with radiation takes advantage of how radiation can make cancer cells more visible to the immune system. Continuing immunotherapy after radiation and surgery helps maintain immune surveillance against any remaining cancer cells.

Early trial results suggest that adding immunotherapy to standard treatment may improve outcomes for some patients with stage III laryngeal cancer. However, not all patients respond equally to immunotherapy. Researchers are working to identify which patients are most likely to benefit from these treatments. One important factor is whether the cancer is associated with human papillomavirus (HPV) infection, as HPV-positive cancers often respond better to immunotherapy.^[4]

Targeted Therapy Approaches

Targeted therapy uses drugs that specifically attack cancer cells by interfering with particular molecules needed for tumor growth and survival. Unlike chemotherapy that affects all rapidly dividing cells, targeted therapies zero in on specific abnormalities in cancer cells, potentially causing fewer side effects.

Clinical trials are exploring targeted therapies for laryngeal cancer, though many remain in earlier research phases. Some targeted drugs being studied aim to block growth signals that cancer cells use to multiply uncontrollably. Others target the formation of new blood vessels that tumors need to grow beyond a certain size. These approaches are still being evaluated for safety and effectiveness in stage III laryngeal cancer.

Clinical Trial Phases and What They Mean

Understanding clinical trial phases helps patients make informed decisions about participation. Phase I trials primarily assess safety, determining the appropriate dose of a new treatment and identifying side effects. These trials typically involve small numbers of participants and are the first time a treatment is tested in humans.^[1]

Phase II trials evaluate whether the treatment works against cancer. These studies enroll more patients and look at response rates—how many patients experience tumor shrinkage or cancer control. Phase II trials also continue monitoring safety and side effects. Many immunotherapy and targeted therapy studies for stage III laryngeal cancer are currently in Phase II.^[1]

Phase III trials compare new treatments against current standard treatments. These large studies enroll hundreds or thousands of patients randomly assigned to receive either the new treatment or the standard treatment. Phase III trials provide the strongest evidence about whether a new treatment is better than existing options. Successful Phase III trials typically lead to treatment approval by regulatory agencies.^[1]

Clinical Trial Locations and Eligibility

Clinical trials for stage III laryngeal cancer are conducted at major cancer centers across the United States, Europe, and other regions worldwide. Many trials require specific eligibility criteria, such as particular stage of disease, previous treatments received (or not received), overall health status, and sometimes specific tumor characteristics like HPV status.

Patients interested in clinical trials should discuss options with their medical team. Doctors can search clinical trial databases to find relevant studies and help determine eligibility. Some trials are available only at specialized cancer centers, which may require travel, while others are conducted at multiple sites, increasing accessibility.

Most common treatment methods

• Surgery
  • Transoral surgery through the mouth to remove tumors using specialized instruments or lasers while preserving surrounding tissue
  • Laryngopharyngectomy removing part or all of the larynx, pharynx, and sometimes esophagus for more extensive cancers
  • Neck dissection to remove lymph nodes that may contain cancer cells
  • Tracheostomy creating an opening for breathing when needed
  • Gastrostomy tube placement to ensure adequate nutrition during recovery
  • Reconstructive surgery to restore appearance and function after cancer removal
• Chemoradiation (Combined Chemotherapy and Radiation)
  • Cisplatin chemotherapy given during radiation treatment to make cancer cells more vulnerable to radiation
  • Fluorouracil (5-FU) sometimes combined with cisplatin to disrupt cancer cell growth
  • Intensity-Modulated Radiation Therapy (IMRT) precisely targeting tumors while protecting healthy tissue
  • Radiation directed at primary tumor and lymph nodes on both sides of the neck
  • Treatment typically lasting six to seven weeks with radiation five days weekly
• Adjuvant Radiation Therapy
  • Radiation given after surgery to eliminate microscopic cancer cells
  • Sometimes combined with chemotherapy for high-risk features found during surgery
  • Reduces risk of cancer recurrence in the treated area
• Immunotherapy (in Clinical Trials)
  • Pembrolizumab (Keytruda) blocking PD-1 protein to help immune system attack cancer
  • Given before surgery, with radiation therapy, and continued afterward in sequential approach
  • Particularly studied for locally advanced stage III cancers
• Supportive Care
  • Speech and language therapy before, during, and after treatment to maintain swallowing and voice function
  • Nutritional support from dietitians to manage eating difficulties and maintain adequate nutrition
  • Pain management to control discomfort during and after treatment
  • Anti-nausea medications to control chemotherapy side effects

Survival and Prognosis for Stage III Laryngeal Cancer

Understanding survival statistics helps set realistic expectations, though remember that statistics describe large groups of people and cannot predict what will happen to any individual patient. Survival for stage III laryngeal cancer depends on multiple factors including tumor location, whether vocal cords can still move, presence of lymph node involvement, overall health, age, and response to treatment.^[1]

Statistics from England covering people diagnosed between 2014 and 2016 show that approximately 55 out of 100 adults (around 55%) with stage III laryngeal cancer survive for five years or more after diagnosis. This five-year survival figure is a standard measure used to evaluate cancer outcomes, though many people live much longer than five years.^[23]

These survival statistics reflect all types of stage III laryngeal cancer together, but individual prognosis varies based on specific characteristics. Cancers confined to the larynx with vocal cord fixation but no lymph node spread may have better outcomes than cancers that have spread to a lymph node. Similarly, smaller lymph node involvement generally has better prognosis than larger nodes.

The choice of treatment significantly impacts survival. Research comparing surgery-based treatment to chemoradiotherapy for stage III laryngeal cancer found differences in outcomes. A large population-based study using sophisticated statistical analysis to account for differences between patient groups found that surgery-based treatment resulted in significantly better disease-specific survival compared to chemoradiotherapy alone.^[9] However, this doesn’t mean surgery is always the best choice for every patient. The decision must balance cancer control with functional outcomes and quality of life.

Beyond the five-year mark, many patients continue living cancer-free lives. Long-term surveillance remains important because laryngeal cancer can sometimes recur years after successful treatment. Additionally, people who had laryngeal cancer have increased risk of developing second cancers, particularly in the head and neck region, lungs, or esophagus, especially if tobacco and alcohol use continue.

Follow-up Care and Monitoring

After completing treatment for stage III laryngeal cancer, regular follow-up appointments are essential for monitoring recovery, detecting any cancer recurrence early, and managing long-term side effects. Follow-up typically involves frequent visits in the first year after treatment, with gradually decreasing frequency over subsequent years.^[22]

During follow-up appointments, doctors perform thorough examinations of your throat and neck, often using specialized scopes to look at the larynx and surrounding areas. Imaging tests like CT or PET scans may be ordered at specific intervals or if concerning symptoms develop. Blood tests might monitor general health and detect any issues related to previous treatment.

Follow-up visits also provide opportunity to address ongoing side effects and rehabilitation needs. Speech and swallowing function may continue improving for months or even years after treatment ends. Working with speech and language therapists, nutritionists, and other specialists helps optimize long-term function and quality of life.

Lifestyle modifications become crucial during the survivorship period. Quitting tobacco and alcohol use is perhaps the most important step, as continued use increases risk of recurrence and second cancers. Maintaining good nutrition, staying physically active within your capabilities, and managing stress contribute to overall health and well-being after cancer treatment.